Specify Company / Ticker to Get the Summary
CorMedix Inc
CRMDCorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Analytics
WallStreet Target Price
16.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CRMD
Dividend Analytics CRMD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CRMD
Stock Valuation CRMD
Financials CRMD
Results | 2019 | Dynamics |